Prednisone Dosing for Children
For children with autoimmune hepatitis or other inflammatory conditions requiring corticosteroid therapy, initiate prednisone at 2 mg/kg/day (maximum 40 mg/day) as a single morning dose, which provides superior efficacy compared to weight-based dosing of 0.5 mg/kg/day while minimizing HPA axis suppression. 1
Weight-Based Dosing Strategy
The most recent 2025 British Society of Gastroenterology guidelines specifically recommend:
- Initial dose: Up to 2 mg/kg/day in children (maximum 40 mg daily) 1
- Timing: Single morning dose before 9 am to minimize adrenal suppression 2
- Adult comparison: Adults receive approximately 0.5 mg/kg/day, but children require higher weight-based dosing 1
The 2025 EASL guidelines corroborate this approach, noting that higher doses (up to 1 mg/kg/day) result in superior biochemical response rates in severe disease, though at the cost of increased adverse effects 3.
Body Surface Area vs Weight-Based Dosing
Critical dosing consideration: Weight-based dosing systematically underdoses younger children compared to BSA-based calculations. Research demonstrates:
- Children <30 kg receive significantly lower doses when using 2 mg/kg compared to 60 mg/m² 4, 5
- This underdosing correlates with increased frequently-relapsing courses (16.6% relative underdosing in frequent relapsers vs 8.7% in infrequent relapsers, p=0.03) 4
- Practical solution: Use simplified equations when height unavailable:
- For 60 mg/m²: [2 × weight in kg + 8]
- For 40 mg/m²: [weight in kg + 11] 6
These equations predict BSA-based doses with 97-98% accuracy and prevent systematic underdosing in younger children.
Duration of Therapy
Initial Episode (Acute Therapy)
High-certainty evidence shows no benefit to prolonging initial therapy beyond 2-3 months 7:
- 2 months vs 3+ months: No difference in frequent relapses (RR 0.99,95% CI 0.82-1.19) or any relapse at 12-24 months
- 3 months vs 5-7 months: Similarly equivalent outcomes (RR 0.99,95% CI 0.74-1.33)
- Longer courses increase adverse effects without improving outcomes 7
Recommended initial regimen:
- Daily prednisone 2 mg/kg (max 40 mg) for 4-6 weeks
- Followed by alternate-day dosing for 4-6 weeks
- Total duration: 2-3 months maximum 7
Relapsing Disease (Longer-Term Therapy)
For children with relapsing courses:
- Lower induction doses may be equally effective: 1 mg/kg achieves similar remission times as 2 mg/kg with 20.6 mg/kg less total prednisone exposure 7
- Single daily dosing superior to divided doses: Single morning dose causes less HPA suppression (83% vs 100%, p=0.02) and longer time to first relapse (131 vs 28 days, p=0.002) 8
- During intercurrent infections: Daily prednisone during viral infections reduces relapse risk compared to continuing alternate-day dosing 7
Administration Principles
Timing and food considerations 2:
- Administer before 9 am as single dose to align with circadian cortisol rhythm
- Give with food or milk to reduce gastric irritation
- Consider antacids between meals for high-dose therapy
- Multiple daily doses should be evenly spaced only if specifically required
Tapering Strategy
Never abruptly discontinue 2:
- Taper in small increments at appropriate intervals
- Individualize based on clinical response and biochemical markers 1, 3
- Monitor for disease flare during taper
- Patients remain vulnerable to stress during HPA axis recovery
Common Pitfalls
Underdosing young children: Using 2 mg/kg in children <30 kg delivers substantially less than BSA-equivalent dosing—use the simplified equations above 6, 4, 5
Divided daily dosing: Increases HPA suppression and shortens time to relapse compared to single morning dosing 8
Excessive duration: Prolonging initial therapy beyond 2-3 months increases adverse effects without improving outcomes 7
Afternoon/evening administration: Disrupts circadian rhythm and increases Cushingoid effects 2
Monitoring Requirements
The 2025 BSG guidelines mandate monitoring for 1:
- Bone marrow suppression (if on concurrent azathioprine)
- Growth parameters
- Blood pressure and glucose
- Intraocular pressure (baseline and periodic—two-thirds of children develop elevated pressure, mostly asymptomatic) 3
- Infection risk (ensure vaccinations current before starting)
Special Populations
Decompensated cirrhosis or uncertain diagnosis: Consider steroid monotherapy at 0.5 mg/kg/day (max 40 mg) with expectation of short treatment duration 1
Severe/advanced disease: May require up to 1 mg/kg/day initially, accepting higher adverse effect risk for improved biochemical response 3